7/2/2007

Peter Kellogg, chief financial officer for Biogen Idec, is leaving the firm to hold the same position at Merck and serve as an executive vice president. Kellogg, who presided over Biogen's 2003 merger with Idec, will manage Merck's business relationships with AstraZeneca and DuPont.

Related Summaries